What type of study is this?

This is a Experimental Study study.

October 15, 2025AggregateOpen Access

Triplet Energy Transfer‐Sensitized NIR‐II Luminescent Nanoprobes for Ultrasensitive Detection of Prostate‐Specific Antigen

View Full Paper

Ask AI

Bookmark

Authors

HGHang GaoBinzhou Medical University YLY. LiuNanyang Technological University LLLi‐Juan LiuFujian Medical University

Discussion

Member takes

Implication

A TET‐DLISA method achieves ultrasensitive prostate-specific antigen detection in clinical samples, suggesting improved monitoring for prostate cancer.

Key Points

The TET‐DLISA platform detects prostate-specific antigen at a limit of 98 fg mL−1, showcasing a 273 signal-to-background ratio.
Utilizing size-optimized downshifting nanoparticles, this method increases NIR‐II emission by 284 times through energy transfer.
Validation with patient sera reveals a strong correlation with commercial assay results, indicating clinical relevance.
This approach may transform biomarker detection by providing more sensitive tools for precision diagnostics.

Cite This Study

Gao et al. (2025) studied this question.

synapsesocial.com/papers/68eff7392ae617e5891a92c7 https://doi.org/10.1002/agt2.70178

View Full Paper

Ask AI

Bookmark

Implication

A TET‐DLISA method achieves ultrasensitive prostate-specific antigen detection in clinical samples, suggesting improved monitoring for prostate cancer.

Triplet Energy Transfer‐Sensitized NIR‐II Luminescent Nanoprobes for Ultrasensitive Detection of Prostate‐Specific Antigen

Discussion

Member takes

Implication

Key Points

Cite This Study

Triplet Energy Transfer‐Sensitized NIR‐II Luminescent Nanoprobes for Ultrasensitive Detection of Prostate‐Specific Antigen

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider